Loading
companiesCompany
Korean Gynecologic Oncology Group
The Korean Gynecologic Oncology Group is the Korean incorporated association that runs gynaecological cancer trials; in OnCo it leads a phase 2 study of progestin with a levonorgestrel intrauterine system for fertility-sparing treatment of early endometrial cancer.
Also called: KGOG대한부인종양연구회
Overview
The Korean Gynecologic Oncology Group (KGOG, 사단법인 대한부인종양연구회) is an incorporated association with its office at Yeongil Building, 32 Nambusunhwan-ro 333-gil, Seocho-gu, Seoul (kgog.org, which also lists its semi-annual meetings). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class) of NCT01594879 (phase 2, medroxyprogesterone acetate with a levonorgestrel-releasing intrauterine system in young women with early endometrial cancer), the trial recorded in OnCo. It has no products of its own.
Headquarters
Seoul, KR
Website
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Korean Gynecologic Oncology Group, including child institutions. 5 works · 43 citations · 100% open access · 0% clinical trials · 0% reviews.
Oncology works per year
02022
12023
32024
12025
02026
Most works
- Anita Monika Chudecka-Glaz4 works
- Shin Nishio4 works
- Robert Michael Wenham4 works
- Carol A Aghajanian4 works
- Aikou Okamoto4 works
- S. Lheureux3 works
- Myong Cheol Lim3 works
- Mehmet Ali Vardar3 works
- María Jesús Rubio-Pérez2 works
- Renaud Sabatier2 works
Most cited
Similar pages
- CompanyARCAGY-GINECO
Shares Endometrial cancer and the tag cooperative-group.
- CompanyTROG Cancer Research
Shares Endometrial cancer and the tag cooperative-group.
- CompanyGOG Foundation
Shares Endometrial cancer and the tag cooperative-group.
- CompanyNRG Oncology
Shares Endometrial cancer and the tag cooperative-group.
- PersonSébastien Armanet
Shares Endometrial cancer and the tag cooperative-group.
- TreatmentProgestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)
Shares Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer, Endometrial cancer.